4968-68-7

Upstream product

• 10299-44-2 8-azaadenosine 
• 109451-10-7 O^2'_,O3'_,O5'-triacetyl-2-methylsulfanyl-8-aza-adenosine 
• 82631-14-9 3-(2',3'-O-isopropylidine-5'-O-tertbutyldiphenylsilyl β-D-ribofuranosyl) vic triazolo<4,5-d>pyrimid-7-one 
• 82631-10-5 5-amino-4-carboxamido-1(2',3'-O-isopropylidene-5-O-t-butyldiphenyl silyl β-D-ribofuranosyl)-vic triazole 
• 29168-77-2 3-(2',3'-O-isopropylidene β-D-ribofuranosyl) vic triazolo<4,5-d>pyrimid-7-one 

Downstream Products

• 4546-74-1 7H-3,6-dihydro-1,2,3-triazolo[4,5-d]pyrimidin-7-one 2'-deoxy-β-D-ribonucleoside 
• 588698-74-2 3-((2R,3R,4R,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-((tert-butyldimethylsilyl)oxy)-4-hydroxytetrahydrofuran-2-yl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7(6H)-one 

Relevant academic research and scientific papers

Substrate analogues for an RNA-editing adenosine deaminase: Mechanistic investigation and inhibitor design

ADARs are adenosine deaminases that act on RNA and are responsible for RNA-editing reactions that occur in eukaryotic mRNAs, including the mRNAs of glutamate and serotonin receptors. ADARs capable of editing biologically relevant RNA substrates have been